SCHEMBL10162480

SCHEMBL10162480

CC(C)N1CCC(c2ccc(N3CCOCC3)cc2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
GAA P10253 1/20 0.42
ALOX12 P18054 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PKM P14618 1/20 0.41
GRM2 Q14416 1/20 0.40
PIK3CA P42336 1/20 0.40
ESRRB O95718 1/20 0.40
ESR1 P03372 1/20 0.40
ESRRG P62508 1/20 0.40
PRKDC P78527 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26284924 0.89 ALDH1A1 (0.45) ALDH1A1MAPTGAAALOX12KDM4E
SCHEMBL10161185 0.80 GRM2 (0.45) ALDH1A1MAPTKDM4EMEN1HTT
SCHEMBL14544201 0.78 RAB9A (0.47) ALDH1A1MAPTGAAMEN1HTT
SCHEMBL10162465 0.78 KMT2A (0.46) ALDH1A1MAPTGAAKDM4EMEN1
SCHEMBL8038871 0.76 QDPR (0.47) ALDH1A1MAPTGAAKDM4EMEN1
SCHEMBL23993613 0.76 KCNH2 (0.47) MAPTESRRBESR1ESRRGPDE9A
SCHEMBL16980529 0.76 HPGD (0.46) ESRRBESR1ESRRGPARP1DRD2
SCHEMBL2603286 0.76 KCNH2 (0.47) MAPTESRRBESR1ESRRGPDE9A
SCHEMBL20995105 0.76 ESRRG (0.44) ALDH1A1MAPTGAAMEN1HTT
SCHEMBL26869113 0.76 DRD2 (0.50) ESRRBESR1ESRRGPARP1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165320-A1 NOVEL AZABICYCLOHEXANES PANACEA BIOTEC LTD. (IN) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165320-A1 NOVEL AZABICYCLOHEXANES CYP3A43, UGT1A1, CYP3A4 ALDH1A1 295/4885MAPT 219/4885GAA 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.